Policy paper

Vaccine research relief: expiry in 2017

This tax information and impact note applies to companies that carry out R&D into prescribed types of vaccine and other medicine.

Document

Details

This measure provides for the expiry of vaccine research relief, in respect of expenditure incurred on or after 1 April 2017.

Published 16 March 2016